Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Debruyne

Showing results (501-510 of 505) with videos related to

Pageof 51
Sort By:
You have reached the last page of results.This site can display upto 505 results.
European Urology|October 31, 2001
Microvessel density: correlation between contrast ultrasonography and histology of prostate cancerJ P Sedelaar, G J van Leenders, C A Hulsbergen-van de Kaa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250M G Steffens, O C Boerman, J C Oosterwijk-Wakka, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancerE C De Boer, W H De Jong, P A Steerenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Phase I radioimmunotherapy of metastatic renal cell carcinoma with 131I-labeled chimeric monoclonal antibody G250M G Steffens, O C Boerman, P H de Mulder, et al.
The Journal of Urology|April 1, 1996
A new long acting formulation of the luteinizing hormone-releasing hormone analogue goserelin: results of studies in prostate cancerF M Debruyne, G A Dijkman, D C Lee, et al.
Pageof 51

Showing results (501-510 of 505) with videos related to

Sort By:
Pageof 51
You have reached the last page of results.This site can display upto 505 results.
European Urology|October 31, 2001
Microvessel density: correlation between contrast ultrasonography and histology of prostate cancerJ P Sedelaar, G J van Leenders, C A Hulsbergen-van de Kaa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250M G Steffens, O C Boerman, J C Oosterwijk-Wakka, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancerE C De Boer, W H De Jong, P A Steerenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Phase I radioimmunotherapy of metastatic renal cell carcinoma with 131I-labeled chimeric monoclonal antibody G250M G Steffens, O C Boerman, P H de Mulder, et al.
The Journal of Urology|April 1, 1996
A new long acting formulation of the luteinizing hormone-releasing hormone analogue goserelin: results of studies in prostate cancerF M Debruyne, G A Dijkman, D C Lee, et al.
Pageof 51